Official recall notice

FDA DrugClass IINotable

Semaglutide Glycine Recall (Aug 2026) – Apollo Care

Product: SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01

Recall date
2026-08-19
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Affected products

Lot: AC-017273, Exp. 12/12/2026.

Verify with the official notice →
Share:

Related Recalls

2026-08-19 · FDA_DRUG
FDA Recall: SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection
Apollo Care, LLC
2026-08-19 · FDA_DRUG
FDA Recall: SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For S
Apollo Care, LLC
2026-08-19 · FDA_DRUG
FDA Recall: SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Onl
Apollo Care, LLC
2026-08-19 · FDA_DRUG
FDA Recall: SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Onl
Apollo Care, LLC